Want to join the conversation?
Ben Bienvenu of Stephens Inc. asks about comp sales improvement in 2H16. $FRED said it initially expected 3Q16 to be worse than 4Q16 but the environment has changed and there is more competition in its category. Although $FRED expects comps to be better, with the investment in price, it does not expect any big improvement in profits.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?